In February 2024, MedJ signed a strategic cooperation agreement with Japan's leading doctor platform CareNet. The two parties will focus on the core needs of clinical experts from China and Japan, sharing global advanced concepts and building an academic cooperation platform in the areas of clinical experience exchange and academic promotion of innovative medical devices.

Figure: CareNet's announcement of the cooperation on its official website
In recent years, China's innovative drug market has developed rapidly, with dozens of innovative drugs approved each year to benefit patients, and the Chinese pharmaceutical market is rapidly developing in a professional direction. At the same time, China's innovative medical device market is in its infancy, and the domestic substitution of high-end medical devices and going global has become a major trend. However, the vast territory of the Chinese market and the uneven medical level have posed greater challenges to the professionalism and knowledge renewal of clinical doctors in understanding and rational use of innovative medical devices.
CareNet, the leading doctor platform in Japan that has signed a strategic cooperation with "Medical Community," has accumulated nearly 30 years of experience in medical education and doctor services, accurately covering more than 70% of Japanese doctors, and has accumulated a large amount of professional academic content, as well as experience in academic promotion products and services. CareNet has explored a compliant and successful path, continuously establishing and strengthening relationships with KOLs and professional doctors to help more clinical doctors improve their level, thereby providing high-quality, high-value, patient-centered treatment plans based on the latest developments in the field.
MedJ hopes to enhance its core competitiveness in the field of doctor services by introducing CareNet's content and experience. At the same time, CareNet also hopes to gain opportunities to expand its business in China and Asia through cooperation with "Medical Community." Since the first half of last year, MedJ and CareNet began to contact each other; at the end of September last year, the senior management team of MedJ went to Tokyo to have in-depth communication with the senior management team of CareNet, further clarifying the business fit and the recognition of business philosophy, and finally signed the strategic cooperation agreement.

Figure: A photo of MedJ founder Chen Qi Rui (right) and CareNet founder Oono Gen Tai at CareNet's Tokyo headquarters
After the strategic cooperation with CareNet, MedJ first plans to promote CareNet's advantage product - Charm Surgery in the field of oncology surgery, introducing the other party's high-quality content and operational experience to empower MedJ in the exchange of Chinese and Japanese experts in the field of oncology, both online and offline, as well as academic promotion of innovative medical devices, thereby consolidating "Medical Community"'s competitiveness in this field. In addition, the two parties will also explore joint proposals to global pharmaceutical companies to ensure the quality of academic promotion services in the two major markets of China and Japan. In the future, the two parties will also consider further deepening cooperation to jointly expand the Asian market.

Figure: Mr. Fujii Koji, CFO of CareNet, recorded a video for MedJ 2023 annual meeting, expressing expectations for the cooperation between the two parties
Looking forward to the platform for the exchange of clinical experience between Chinese and Japanese doctors built by MedJ and CareNet, which can contribute to the spread of China's clinical "good voice" to the world, and explore a new paradigm of Global To China, China To Global in the academic promotion of innovative medical devices!